ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01369498
Recruitment Status : Completed
First Posted : June 9, 2011
Last Update Posted : November 13, 2015
Sponsor:
Information provided by (Responsible Party):
Gilead Sciences

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2014
  Actual Study Completion Date : September 2014
  Certification/Extension First Submitted : October 22, 2015